Cipta Sarana Medika Tbk. vs Logindo Samudramakmur Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp64 (market cap 160.67B, 14.05M 24h volume), while Logindo Samudramakmur Tbk. trades at Rp108 (market cap 655.36B, 15.22M 24h volume). The key difference: Logindo Samudramakmur Tbk. is far larger — about 4.1× Cipta Sarana Medika Tbk.'s market cap, and Logindo Samudramakmur Tbk. is more actively traded (15.22M versus 14.05M). Which is the better fit depends on your goals.
| DKHH | LEAD | |
|---|---|---|
Market Cap | 160.67B | 655.36B |
Volume | 14.05M | 15.22M |
Lot | 140.49K | 152.25K |
Turnover | 899.67M | 1.67B |
Average Price | 64.04 | 109.39 |
Value | 899.67M | 1.67B |
Indicative Equilibrium Price | 64 | 108 |
Indicative Equilibrium Volume | 100 | 1.95K |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Logindo Samudramakmur Tbk (the Company) is domiciled and was established in Jakarta, Indonesia based on Notarial Deed No. 55 of Nurul Hidajati Handoko, SH., Public Notary in Jakarta dated August 23, 1995. The company currently owns and operates a fleet of 58 offshore support with various types and functions. The company has a portfolio of customers ranging from mining oil and gas local to multinational.
Read more on LEAD →